Search results

Selected filters:

Europe
Market Developments

Article type

Topic

Sector

Jurisdictions

173 results found for your search

Sort options
21 January 2020

Four trends that will shape life sciences IP deal-making in 2020

After a record-breaking 2019, here are the key value-creation issues to look out for in the new decade

16 January 2020

Breaking: EPO Board of Appeal upholds invalidation of Broad’s CRISPR-Cas9 patent

Surprise move means Enlarged Board will not now be asked to consider key questions that were referred to it yesterday

15 January 2020

Updated: Broad Institute faces tough fight in CRISPR patent appeal hearing

Oral hearings before the EPO’s Boards of Appeal may have a big impact on the European Cas9 landscape

09 January 2020

NPE’s litigation move may be a sign of things to come in the healthcare sector

Move by Parallax Health Sciences is an indication that patent assertion plays could increasingly affect life sciences companies as their use of digital technologies increases

17 December 2019

We are working with pharma companies better than ever before, says top university patent dealmaker

In an exclusive interview, Adam Stoten, the of COO Oxford University Innovation - one of Europe’s largest tech transfer offices - explains the challenges of protecting and commercialising early-stage life sciences inventions

05 December 2019

Auto IP stakeholders in Asia call for peace, prepare for war

Huawei, Nokia and top Japanese brands discussed the licensing conflicts confronting the industry in front of a packed room in Shanghai

05 December 2019

The search for the world's leading IP strategists is on

IAM is currently seeking nominations for individuals to be considered for the 2020 edition of the Strategy 300 - our unique guide to the men and women who excel in the creation of IP value

04 December 2019

What leaked US trade talks tell us about future of UK pharma IP

Secret government documents detailing pharma patent discussions between UK and US officials have stirred up a controversy in the run up to the British general election later this month

26 November 2019

Korean company plans to auction 5G, LED rights

Seoul Semiconductor is kicking off a “new patent management strategy” with two portfolios going under the hammer later this year

22 November 2019

Three key dynamics facing automakers in Asia

IAM is bringing the region’s IP leaders together in Shanghai on December 5th for the inaugural Auto IP Asia conference

22 November 2019

Despite possible German Constitutional Court breakthrough, don't bet on the UPC's fate becoming clearer any time soon

In controversial interview, wrongly labelled by some as "fake news", judge says a decision on legality of Germany's ratification could be handed down early next year - but even if it happens many issues remain to be resolved, notably the role the UK might play

19 November 2019

Shorter EPO opposition process requires new approaches from life sciences patentees

Strategies employed not only by rights owners but also by those opposing their grants will need to be recalibrated to reflect the new realities

14 November 2019

Skyhawk deal with Celgene confirms growing importance of platform technologies in life sciences IP value creation

Increased focus on gene and cell-related therapies as well as falling R&D returns, promise to heighten biopharma interest in tapping into the potential of SkySTAR and other platforms

12 November 2019

US government patent suit against Gilead could be a sign of things to come

After months of Truvada controversy, Department of Justice files multi-billion dollar case against Gilead, claiming the company has declined to take a licence to its HIV PrEP rights since in 2016

08 November 2019

Catch up on the most important life sciences IP developments from the past month

Read our most recent monthly round-up for key pharma and biotech IP stories from October 2019